AN1
Click for more information
0.00% 0.8¢ anagenics limited

Ann: Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory, page-36

  1. DeeGeeBee
    23 Posts.
    lightbulb Created with Sketch. 8
    clock Created with Sketch.
    13/07/20
    15:28
    Post #: 45829317
    Bariscan - you've just unlocked CDY's growth strategy... biggrin.png

    Shareholder purchases CDY stock --> CDY let shareholders down, time and time again with no material announcements --> Shareholder pulls hair out --> Shareholder purchases Evolis Hair Tonic --> Evolis sales take off --> Share price increases --> Shareholders happy
    CDY Price at posting: 12.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 14  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $4.704K 588K

Buyers (Bids)

No. Vol. Price($)
1 697002 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 15.07pm 03/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.